geraalvarez.com

The PDX ROS1-fusion tumor cell line, LUAD-0006, is resistant to

By A Mystery Man Writer

PDF) NRG1 and NRG2 fusion positive solid tumor malignancies: a paradigm of ligand-fusion oncogenesis

Sudarshan Iyer's research works

Inna Khodos's research works Memorial Sloan Kettering Cancer

Inna Khodos's research works Memorial Sloan Kettering Cancer

Igor Odintsov's research works Brigham and Women's Hospital

CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles, Journal of Translational Medicine

Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development. - Abstract - Europe PMC

Igor Odintsov's research works Brigham and Women's Hospital

PDF) Pre-clinical modelling of ROS1+ non-small cell lung cancer